Marksans Pharma Ltd NSE  /  BSE

Pharmaceuticals, Mid Cap

13 Dec 2018 | 03:59 PM

28.15
-0.20 (-0.71%)

  • Underperforms Index

    -20.37%

    Return (1Y)

    Underperformed S&P BSE Healthcare by 20.12%

  • More Volatile

    3.21%

    Standard Deviation (1Y)

    Higher than S&P BSE Healthcare by 2.07%

  • Not so consistent

    5/12

    Months

    underperformed S&P BSE Healthcare

  • AxisDirect View

    No View

52 Week High-Low

50

50.25

24

23.55

News & Announcements

Price vs Volume

Stock Trivia

  • FII shareholding in Marksans Pharma Ltd has decreased by -30.48% since past 3 Months

  • FII shareholding in Marksans Pharma Ltd has decreased by -61% since past 1 Year

Loading...